Surgery and Anesthesia in Patients with Pulmonary Hypertension

 

 Buy Article Permissions and Reprints

Abstract

Pulmonary hypertension is characterized by right ventricular impairment and a reduced ability to compensate for hemodynamic insults. Consequently, surgery can be challenging but is increasingly considered in view of available specific therapies and improved longer term survival. Optimal management requires a multidisciplinary patient-centered approach involving surgeons, anesthetists, pulmonary hypertension clinicians, and intensivists. The optimal pathway involves risk:benefit assessment for the proposed operation, optimization of pulmonary hypertension and any comorbidities, the appropriate anesthetic approach for the specific procedure and patient, and careful monitoring and management in the postoperative period. Where patients are carefully selected and meticulously managed, good outcomes can be achieved.

^* Equal contribution.

Publication History

Article published online:
20 September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Humbert M, Kovacs G, Hoeper MM. et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023; 61 (01) 2022
  CrossrefPubMedGoogle Scholar
• 2 McGlothlin DP, Granton J, Klepetko W. et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41 (09) 1135-1194
  CrossrefPubMedGoogle Scholar
• 3 Ling Y, Johnson MK, Kiely DG. et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012; 186 (08) 790-796
  CrossrefPubMedGoogle Scholar
• 4 Condliffe R, Kiely DG, Gibbs JS. et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008; 177 (10) 1122-1127
  CrossrefPubMedGoogle Scholar
• 5 Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ 2021; 11 (01) 2045894020977300
  CrossrefPubMedGoogle Scholar
• 6 Hurdman J, Condliffe R, Elliot CA. et al. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J 2012; 39 (04) 945-955
  CrossrefPubMedGoogle Scholar
• 7 Galiè N, Barberà JA, Frost AE. et al; AMBITION Investigators. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015; 373 (09) 834-844
  CrossrefPubMedGoogle Scholar
• 8 Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009; 53 (13) 1119-1126
  CrossrefPubMedGoogle Scholar
• 9 Leung CC, Moondra V, Catherwood E, Andrus BW. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010; 106 (02) 284-286
  CrossrefPubMedGoogle Scholar
• 10 Shah AM, Claggett B, Sweitzer NK. et al. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 2014; 7 (05) 740-751
  CrossrefPubMedGoogle Scholar
• 11 Vachiéry JL, Tedford RJ, Rosenkranz S. et al. Pulmonary hypertension due to left heart disease. Eur Respir J 2019; 53 (01) 1801897
  CrossrefPubMedGoogle Scholar
• 12 Bermejo J, Yotti R, García-Orta R. et al; Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. Eur Heart J 2018; 39 (15) 1255-1264
  CrossrefPubMedGoogle Scholar
• 13 Abraham AS, Cole RB, Green ID, Hedworth-Whitty RB, Clarke SW, Bishop JM. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res 1969; 24 (01) 51-60
  CrossrefPubMedGoogle Scholar
• 14 Kiely DG, Condliffe R. Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow. Eur Respir J 2021; 58 (02) 58
  CrossrefPubMedGoogle Scholar
• 15 Waxman A, Restrepo-Jaramillo R, Thenappan T. et al. Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease. N Engl J Med 2021; 384 (04) 325-334
  CrossrefPubMedGoogle Scholar
• 16 Kim NH, Delcroix M, Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53 (01) 53
  CrossrefPubMedGoogle Scholar
• 17 Vonk Noordegraaf A, Chin KM, Haddad F. et al. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 2019; 53 (01) 53
  CrossrefPubMedGoogle Scholar
• 18 Price LC, Dimopoulos K, Marino P. et al. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension. Thorax 2017; 72 (11) 1035-1045
  CrossrefPubMedGoogle Scholar
• 19 Smilowitz NR, Armanious A, Bangalore S, Ramakrishna H, Berger JS. Cardiovascular outcomes of patients with pulmonary hypertension undergoing noncardiac surgery. Am J Cardiol 2019; 123 (09) 1532-1537
  CrossrefPubMedGoogle Scholar
• 20 Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45 (10) 1691-1699
  CrossrefPubMedGoogle Scholar
• 21 Bauchmuller K, Condliffe R, Southern J. et al. Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry. ERJ Open Res 2021; 7 (02) 7
  CrossrefPubMedGoogle Scholar
• 22 Hoeper MM, Kramer T, Pan Z. et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017; 50 (02) 1700740
  CrossrefPubMedGoogle Scholar
• 23 Boucly A, Weatherald J, Savale L. et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J 2017; 50 (02) 1700889
  CrossrefPubMedGoogle Scholar
• 24 Benza RL, Gomberg-Maitland M, Miller DP. et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012; 141 (02) 354-362
  CrossrefPubMedGoogle Scholar
• 25 Delcroix M, Staehler G, Gall H. et al. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients. Eur Respir J 2018; 52 (05) 52
  CrossrefPubMedGoogle Scholar
• 26 Benza RL, Farber HW, Frost A. et al. REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat. J Heart Lung Transplant 2018; 37 (07) 836-843
  CrossrefPubMedGoogle Scholar
• 27 Rich S. The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension. J Am Coll Cardiol 2012; 60 (13) 1202-1203
  CrossrefPubMedGoogle Scholar
• 28 Lewis RA, Billings CG, Hurdman JA. et al. Maximal exercise testing using the incremental shuttle walking test can be used to risk-stratify patients with pulmonary arterial hypertension. Ann Am Thorac Soc 2021; 18 (01) 34-43
  CrossrefPubMedGoogle Scholar
• 29 Hadinnapola C, Bleda M, Haimel M. et al; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH. Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation 2017; 136 (21) 2022-2033
  CrossrefPubMedGoogle Scholar
• 30 Hoeper MM, Pausch C, Olsson KM. et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J 2022; 60 (01) 60
  CrossrefPubMedGoogle Scholar
• 31 Benza RL, Gomberg-Maitland M, Elliott CG. et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest 2019; 156 (02) 323-337
  CrossrefPubMedGoogle Scholar
• 32 Benza RL, Kanwar MK, Raina A. et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest 2021; 159 (01) 337-346
  CrossrefPubMedGoogle Scholar
• 33 Deljou A, Sabov M, Kane GC. et al. Outcomes after noncardiac surgery for patients with pulmonary hypertension: a historical cohort study. J Cardiothorac Vasc Anesth 2020; 34 (06) 1506-1513
  CrossrefPubMedGoogle Scholar
• 34 Aguirre MA, Lynch I, Hardman B. Perioperative management of pulmonary hypertension and right ventricular failure during noncardiac surgery. Adv Anesth 2018; 36 (01) 201-230
  CrossrefPubMedGoogle Scholar
• 35 Minai OA, Yared JP, Kaw R, Subramaniam K, Hill NS. Perioperative risk and management in patients with pulmonary hypertension. Chest 2013; 144 (01) 329-340
  CrossrefPubMedGoogle Scholar
• 36 Lewis RA, Johns CS, Cogliano M. et al. Identification of cardiac magnetic resonance imaging thresholds for risk stratification in pulmonary arterial hypertension. Am J Respir Crit Care Med 2020; 201 (04) 458-468
  CrossrefPubMedGoogle Scholar
• 37 Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol 2017; 2 (02) 181-187
  CrossrefPubMedGoogle Scholar
• 38 Tartavoulle T, Bonanno LS, Hall S. Perioperative considerations for patients diagnosed with pulmonary hypertension undergoing noncardiac surgery. J Perianesth Nurs 2019; 34 (02) 240-249
  CrossrefPubMedGoogle Scholar
• 39 Badagliacca R, Papa S, Poscia R. et al. The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension. J Heart Lung Transplant 2019; 38 (03) 306-314
  CrossrefPubMedGoogle Scholar
• 40 Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer Jr RM. Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007; 204 (06) 1199-1210
  CrossrefPubMedGoogle Scholar
• 41 Lewis RA, Thompson AAR, Billings CG. et al. Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension. Eur Respir J 2020; 55 (06) 2000041
  CrossrefPubMedGoogle Scholar
• 42 Hoeper MM, Dwivedi K, Pausch C. et al. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis. Lancet Respir Med 2022; 10 (10) 937-948
  CrossrefPubMedGoogle Scholar
• 43 Haque A, Kiely DG, Kovacs G, Thompson AAR, Condliffe R. Pulmonary hypertension phenotypes in patients with systemic sclerosis. Eur Respir Rev 2021; 30 (161) 30
  CrossrefPubMedGoogle Scholar
• 44 Kiely DG, Levin D, Hassoun P. et al. EXPRESS: statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm Circ 2019; 9 (03) 2045894019841990
  CrossrefPubMedGoogle Scholar
• 45 England TRCoSo. The higher risk general surgical patient: towards improved care for a forgotten group. 2011 Accessed August 08, 2023 at: https://www.rcseng.ac.uk/library-and-publications/rcs-publications/docs/the-higher-risk-general-surgical-patient/
  PubMedGoogle Scholar
• 46 Price LC, Martinez G, Brame A. et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth 2021; 126 (04) 774-790
  CrossrefPubMedGoogle Scholar
• 47 Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation 2017; 135 (07) 700-710
  CrossrefPubMedGoogle Scholar
• 48 Jung KT, Kim SH, Kim JW, So KY. Bradycardia during laparoscopic surgery due to high flow rate of CO2 insufflation. Korean J Anesthesiol 2013; 65 (03) 276-277
  CrossrefPubMedGoogle Scholar
• 49 Kiely DG, Cargill RI, Lipworth BJ. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109 (05) 1215-1221
  CrossrefPubMedGoogle Scholar
• 50 Donaldson AJ, Thomson HE, Harper NJ, Kenny NW. Bone cement implantation syndrome. Br J Anaesth 2009; 102 (01) 12-22
  CrossrefPubMedGoogle Scholar
• 51 Ritter J, Hubert J, Kniep I, Beil FT, Rolvien T, Püschel K. Pulmonary cement embolism is frequently observed but not a contributing factor for death in patients with cemented total hip and knee arthroplasty: a postmortem study. Int Orthop 2022; 46 (06) 1225-1232
  CrossrefPubMedGoogle Scholar
• 52 Qi X, Zhang Y, Pan J, Ma L, Wang L, Wang J. Effect of bone cement implantation on haemodynamics in elderly patients and preventive measure in cemented hemiarthroplasty. BioMed Res Int 2015; 2015: 568019
  PubMedGoogle Scholar
• 53 Memtsoudis SG, Ma Y, Chiu YL, Walz JM, Voswinckel R, Mazumdar M. Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg 2010; 111 (05) 1110-1116
  CrossrefPubMedGoogle Scholar
• 54 Seyfarth HJ, Gille J, Sablotzki A. et al. Perioperative management of patients with severe pulmonary hypertension in major orthopedic surgery: experience-based recommendations. GMS Interdiscip Plast Reconstr Surg DGPW 2015; 4: Doc03
  PubMedGoogle Scholar
• 55 Wardle M, Nair A, Saunders S. et al. Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension. Pulm Circ 2022; 12 (01) e12019
  CrossrefPubMedGoogle Scholar
• 56 Yentis SM, Steer PJ, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 1998; 105 (08) 921-922
  CrossrefPubMedGoogle Scholar
• 57 Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31 (07) 1650-1657
  CrossrefPubMedGoogle Scholar
• 58 Bonnin M, Mercier FJ, Sitbon O. et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102 (06) 1133-1137 , discussion 5A–6A
  CrossrefPubMedGoogle Scholar
• 59 Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. Eur Heart J 2009; 30 (03) 256-265
  CrossrefPubMedGoogle Scholar
• 60 Kiely DG, Condliffe R, Webster V. et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 2010; 117 (05) 565-574
  CrossrefPubMedGoogle Scholar
• 61 Kamp JC, von Kaisenberg C, Greve S. et al. Pregnancy in pulmonary arterial hypertension: midterm outcomes of mothers and offspring. J Heart Lung Transplant 2021; 40 (03) 229-233
  CrossrefPubMedGoogle Scholar
• 62 Jaïs X, Olsson KM, Barbera JA. et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J 2012; 40 (04) 881-885
  CrossrefPubMedGoogle Scholar
• 63 Hemnes AR, Kiely DG, Cockrill BA. et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ 2015; 5 (03) 435-465
  CrossrefPubMedGoogle Scholar
• 64 Singh A, Siddiqui MT, Al-Yaman W. et al. Utility of endoscopy in hospitalized patients with gastrointestinal hemorrhage and pulmonary hypertension. Dig Dis Sci 2021; 66 (12) 4159-4168
  CrossrefPubMedGoogle Scholar
• 65 Lai C, Savale L, Boytchev I. et al. Risks and outcomes of gastrointestinal endoscopy with anaesthesia in patients with pulmonary hypertension. Br J Anaesth 2020; 125 (06) e466-e468
  CrossrefPubMedGoogle Scholar
• 66 Diaz-Fuentes G, Bajantri B, Adrish M. Safety of bronchoscopy in patients with echocardiographic evidence of pulmonary hypertension. Respiration 2016; 92 (03) 182-187
  CrossrefPubMedGoogle Scholar
• 67 Ishiwata T, Abe M, Kasai H. et al. Safety of diagnostic flexible bronchoscopy in patients with echocardiographic evidence of pulmonary hypertension. Respir Investig 2019; 57 (01) 73-78
  CrossrefPubMedGoogle Scholar
• 68 Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K. Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. Chest 1988; 93 (05) 960-967
  CrossrefPubMedGoogle Scholar
• 69 Kaye AD, Hoover JM, Kaye AJ. et al. Morphine, opioids, and the feline pulmonary vascular bed. Acta Anaesthesiol Scand 2008; 52 (07) 931-937
  CrossrefPubMedGoogle Scholar
• 70 Ouédraogo N, Mounkaïla B, Crevel H, Marthan R, Roux E. Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery. BMC Anesthesiol 2006; 6: 2
  CrossrefPubMedGoogle Scholar
• 71 Green DW. Cardiac output decrease and propofol: what is the mechanism?. Br J Anaesth 2015; 114 (01) 163-164
  CrossrefPubMedGoogle Scholar
• 72 Colvin MP, Savege TM, Newland PE. et al. Cardiorespiratory changes following induction of anaesthesia with etomidate in patients with cardiac disease. Br J Anaesth 1979; 51 (06) 551-556
  CrossrefPubMedGoogle Scholar
• 73 Jabre P, Combes X, Lapostolle F. et al; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009; 374 (9686) 293-300
  CrossrefPubMedGoogle Scholar
• 74 Gooding JM, Dimick AR, Tavakoli M, Corssen G. A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in noncardiac patients. Anesth Analg 1977; 56 (06) 813-816
  CrossrefPubMedGoogle Scholar
• 75 Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37 (06) 613-619
  CrossrefPubMedGoogle Scholar
• 76 Friesen RH, Twite MD, Nichols CS. et al. Hemodynamic response to ketamine in children with pulmonary hypertension. Paediatr Anaesth 2016; 26 (01) 102-108
  CrossrefPubMedGoogle Scholar
• 77 Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985; 62 (03) 287-293
  CrossrefPubMedGoogle Scholar
• 78 Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982; 57 (01) 9-13
  CrossrefPubMedGoogle Scholar
• 79 Blaudszun G, Morel DR. Superiority of desflurane over sevoflurane and isoflurane in the presence of pressure-overload right ventricle hypertrophy in rats. Anesthesiology 2012; 117 (05) 1051-1061
  CrossrefPubMedGoogle Scholar
• 80 Rich S, Gubin S, Hart K. The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 1990; 98 (05) 1102-1106
  CrossrefPubMedGoogle Scholar
• 81 Kerbaul F, Rondelet B, Motte S. et al. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004; 32 (04) 1035-1040
  CrossrefPubMedGoogle Scholar
• 82 Kwak YL, Lee CS, Park YH, Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*. Anaesthesia 2002; 57 (01) 9-14
  CrossrefPubMedGoogle Scholar
• 83 Hirsch LJ, Rooney MW, Wat SS, Kleinmann B, Mathru M. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100 (03) 796-801
  CrossrefPubMedGoogle Scholar
• 84 Bandyopadhyay D, Lai C, Pulido JN, Restrepo-Jaramillo R, Tonelli AR, Humbert M. Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery. Eur Respir Rev 2021; 30 (162) 30
  CrossrefPubMedGoogle Scholar
• 85 Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008; 109 (05) 816-824
  CrossrefPubMedGoogle Scholar
• 86 Strumpher J, Jacobsohn E. Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management. J Cardiothorac Vasc Anesth 2011; 25 (04) 687-704
  CrossrefPubMedGoogle Scholar
• 87 Kruthiventi SC, Kane GC, Sprung J, Weingarten TN, Warner ME. Postoperative pulmonary complications in contemporary cohort of patients with pulmonary hypertension. Bosn J Basic Med Sci 2019; 19 (04) 392-399
  PubMedGoogle Scholar
• 88 Condliffe R, Kiely DG. Critical care management of pulmonary hypertension. BJA Educ 2017; 17: 228-234
  CrossrefPubMedGoogle Scholar
• 89 Minai OA, Venkateshiah SB, Arroliga AC. Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med 2006; 70 (04) 239-243
  PubMedGoogle Scholar
• 90 Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth 2007; 99 (02) 184-190
  CrossrefPubMedGoogle Scholar
• 91 Price LC, Montani D, Jaïs X. et al. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J 2010; 35 (06) 1294-1302
  CrossrefPubMedGoogle Scholar
• 92 Kaw R, Pasupuleti V, Deshpande A, Hamieh T, Walker E, Minai OA. Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med 2011; 105 (04) 619-624
  CrossrefPubMedGoogle Scholar
• 93 Meyer S, McLaughlin VV, Seyfarth HJ. et al. Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 2013; 41 (06) 1302-1307
  CrossrefPubMedGoogle Scholar
• 94 Bennett JM, Ehrenfeld JM, Markham L, Eagle SS. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome: a review of institutional experience. J Clin Anesth 2014; 26 (04) 286-293
  CrossrefPubMedGoogle Scholar
• 95 Kiely DG, Elliot CA, Sabroe I, Condliffe R. Pulmonary hypertension: diagnosis and management. BMJ 2013; 346: f2028
  CrossrefPubMedGoogle Scholar